| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Oct 9, 2013
Perrigo Company (NYSE, TASE: PRGO) today announced that it has scheduled a shareholder meeting for Monday, November 18, 2013 in connection with...
-
Sep 23, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval for its abbreviated new drug application for nitroglycerin...
-
Sep 20, 2013
PetArmor®, known for its veterinarian-quality products that protect dogs and cats from fleas and ticks, is now also helping to protect four legged K-9s...
-
Sep 20, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced the appointment of Keith Webber as Head of Regulatory Review, effective October 21, 2013. This...
-
Sep 10, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its...
-
Sep 10, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that Perrigo Chairman, President and CEO Joseph C. Papa will present at the Morgan Stanley Global...
-
Aug 15, 2013- Fiscal fourth quarter net sales increased $135 million, or 16%, to $967 million.
Perrigo Company (NYSE: PRGO; TASE: PRGO) today announced results for its fourth quarter and fiscal year ended June 29, 2013. (Logo:...
-
Aug 14, 2013
Perrigo Company (NYSE: PRGO;TASE) today announced that its Board of Directors declared a quarterly dividend of $0.09 per share, payable on September...
-
Aug 12, 2013
Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated...
-
Aug 12, 2013
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) and Perrigo Company (NYSE: PRGO;TASE) today announced the launch of the generic...